Sodium iodide i 131
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
251 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 5 | 23 | 7 | 1 | 18 | 50 |
| Thyroid diseases | D013959 | HP_0000820 | E00-E07 | 5 | 21 | 7 | 1 | 16 | 47 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | 3 | 1 | — | 4 |
| Hypothyroidism | D007037 | EFO_0004705 | E03.9 | 1 | — | 1 | 1 | 1 | 4 |
| Covid-19 | D000086382 | — | — | — | — | — | 1 | — | 1 |
| Sars-cov-2 | D000086402 | — | — | — | — | — | 1 | — | 1 |
| Coronavirus | D017934 | — | — | — | — | — | 1 | — | 1 |
| Viral load | D019562 | — | — | — | — | — | 1 | — | 1 |
| Polymerase chain reaction | D016133 | OBI_0000415 | — | — | — | — | 1 | — | 1 |
| Salivation | D012472 | — | — | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 15 | 32 | 6 | — | 5 | 55 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 10 | 22 | 6 | — | 5 | 42 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 13 | 11 | 3 | — | 9 | 35 |
| Carcinoma | D002277 | — | C80.0 | 4 | 11 | 1 | — | 3 | 17 |
| Leukemia | D007938 | — | C95 | 4 | 5 | 1 | — | — | 10 |
| Follicular lymphoma | D008224 | — | C82 | 3 | 6 | 2 | — | — | 10 |
| B-cell lymphoma | D016393 | — | — | 5 | 3 | 1 | — | — | 9 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 3 | 2 | 1 | — | 3 | 8 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 3 | 3 | 1 | — | — | 7 |
| Myeloid leukemia | D007951 | — | C92 | 3 | 3 | 1 | — | — | 7 |
Show 21 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 17 | 11 | — | — | — | 21 |
| Recurrence | D012008 | — | — | 10 | 8 | — | — | — | 16 |
| Pheochromocytoma | D010673 | — | — | 3 | 4 | — | — | 8 | 14 |
| Papillary thyroid cancer | D000077273 | — | — | 3 | 9 | — | — | 2 | 13 |
| Central nervous system neoplasms | D016543 | — | — | 7 | 5 | — | — | 2 | 12 |
| Nervous system neoplasms | D009423 | — | — | 7 | 4 | — | — | 1 | 10 |
| Follicular adenocarcinoma | D018263 | — | — | 2 | 8 | — | — | — | 9 |
| Syndrome | D013577 | — | — | 3 | 1 | — | — | 4 | 8 |
| Papillary carcinoma | D002291 | — | — | 1 | 7 | — | — | 1 | 8 |
| Paraganglioma | D010235 | — | — | 3 | 2 | — | — | 4 | 8 |
Show 63 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 7 | — | — | — | — | 7 |
| Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | 2 | — | — | — | 1 | 3 |
| T-cell lymphoma | D016399 | — | — | 3 | — | — | — | — | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | — | — | — | — | 3 |
| Mycoses | D009181 | — | B35-B49 | 2 | — | — | — | — | 2 |
| T-cell lymphoma peripheral | D016411 | — | — | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
| Triple negative breast neoplasms | D064726 | — | — | 2 | — | — | — | — | 2 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | — | — | — | — | 2 |
| Measles | D008457 | — | B05 | 1 | — | — | — | — | 1 |
Show 26 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | — | — | — | 5 | 5 |
| Tachycardia | D013610 | HP_0001649 | R00.0 | — | — | — | — | 5 | 5 |
| Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 4 | 4 |
| Graves disease | D006111 | EFO_0004237 | E05.0 | — | — | — | — | 4 | 4 |
| Orthostatic intolerance | D054971 | — | — | — | — | — | — | 2 | 2 |
| Hypovolemia | D020896 | HP_0011106 | E86 | — | — | — | — | 1 | 1 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 1 | 1 |
| Nervous system diseases | D009422 | — | G00-G99 | — | — | — | — | 1 | 1 |
Show 16 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 11,083 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
7,964 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use